Meridian Launches New Range of Lyo-Ready PCR Mixes
February 07 2019 - 7:30AM
Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that
following the successful release of the Lyo-Ready qPCR Mix,
Meridian is proud to introduce its next-generation
lyophilization-ready mixes for one-step RT-qPCR. These master mixes
offer new solutions for developing freeze-dried multiplex assays
that can simultaneously detect both RNA and DNA viruses.
Lyo-Ready One-Step RT-qPCR and Lyo-Ready
One-Step Viral RT-qPCR are glycerol-free formulations that contain
optimized lyophilization excipients, which have been tested with a
range of lyophilization protocols and formats, including cakes and
beads. Their high performance in multiplex reactions in combination
with very fast rehydration times, make them ideally suited for
automated high-throughput platforms. Lyo-Ready One-Step Viral
RT-qPCR has been specifically developed for amplification of RNA
viruses with a high secondary structure.
Molecular diagnostic tests are progressively
moving towards a lyophilized format in order to avoid the need for
a cool chain, leading to considerable cost savings during shipment
and storage. However, there are significant technical challenges in
developing an RT-qPCR lyophilization-compatible mix that has the
same highly reproducible performance as a ‘wet’ formulation.
Building on its expertise in the field of PCR, the life science
division of Meridian Bioscience has successfully developed a range
of ready-to-use, lyophilization-compatible products to suit this
growing demand within the molecular diagnostics industry.
Dr. Lourdes Weltzien, Executive Vice President
of Life Science, commented, “We are delighted to announce the
release of our new Lyo-Ready One-Step RT-qPCR master mixes. We now
have a range of ready-to-use, lyophilization-friendly solutions for
our IVD and biotech customers looking to improve the accuracy of
their assays, increase operational efficiencies and reduce their
overall costs. We remain committed to bringing innovation and
quality products to the IVD community.”
For complete information, please visit
meridianlifescience.com/molecular-dx-reagents.
About Meridian Bioscience,
Inc.
Meridian is a fully integrated life science
company that develops, manufactures, markets and distributes a
broad range of innovative diagnostic products. We are dedicated to
developing and delivering better solutions that give answers with
speed, accuracy and simplicity that are redefining the
possibilities of life from discovery to diagnosis. Through
discovery and development, we provide critical life science raw
materials used in immunological and molecular tests for human,
animal, plant, and environmental applications. Through diagnosis,
we provide diagnostic solutions in areas including gastrointestinal
and upper respiratory infections and blood lead level
testing. We build relationships and provide solutions to
hospitals, reference laboratories, research centers, veterinary
testing centers, physician offices, diagnostics manufacturers, and
biotech companies in more than 70 countries around the world.
Meridian’s shares are traded on the NASDAQ
Global Select Market, symbol VIVO. Meridian’s website address is
www.meridianbioscience.com.
Contact:Jack KennyChief Executive
OfficerMeridian Bioscience, Inc.Phone: 513.271.3700Email:
mbi@meridianbioscience.com
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Sep 2023 to Sep 2024